Circumventing resistance to kinase-inhibitor therapy

Research output: Contribution to journalArticle

114 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2594-2596
Number of pages3
JournalNew England Journal of Medicine
Volume354
Issue number24
DOIs
StatePublished - Jun 15 2006

Fingerprint

Neoplasm Drug Resistance
Piperazines
bcr-abl Fusion Proteins
Thiazoles
Pyrimidines
Protein Kinase Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Antineoplastic Agents
Phosphotransferases
Mutation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Circumventing resistance to kinase-inhibitor therapy. / Druker, Brian.

In: New England Journal of Medicine, Vol. 354, No. 24, 15.06.2006, p. 2594-2596.

Research output: Contribution to journalArticle

@article{feef18001dc441379784ba5fd34824ec,
title = "Circumventing resistance to kinase-inhibitor therapy",
author = "Brian Druker",
year = "2006",
month = "6",
day = "15",
doi = "10.1056/NEJMe068073",
language = "English (US)",
volume = "354",
pages = "2594--2596",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "24",

}

TY - JOUR

T1 - Circumventing resistance to kinase-inhibitor therapy

AU - Druker, Brian

PY - 2006/6/15

Y1 - 2006/6/15

UR - http://www.scopus.com/inward/record.url?scp=33745081606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745081606&partnerID=8YFLogxK

U2 - 10.1056/NEJMe068073

DO - 10.1056/NEJMe068073

M3 - Article

C2 - 16775240

AN - SCOPUS:33745081606

VL - 354

SP - 2594

EP - 2596

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 24

ER -